Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
Schiller
Ampronix

Electronic Nose Sniffs Out Side Effects of Radiotherapy

By Medimaging International staff writers
Posted on 05 Mar 2013
Researchers have recently completed a study that may lead to clinicians being able to more effectively predict which patients will suffer from the side effects of radiotherapy.

Gastrointestinal side effects are typical occurrences in radiotherapy patients and are at times severe, but there are no existing means of predicting which patients will suffer from them. The pilot study’s findings, published September 2012 in the journal Sensors, described how the use of an electronic nose and a newer technology, field asymmetric ion mobility spectrometry (FAIMS) might help identify those at higher risk.

University of Warwick Medical School (Coventry, UK), working in collaboration with the School of Engineering and The Royal Marsden NHS [National Health Service] Foundation Trust (London, UK), led by Dr. J. Andreyev, conducted a pilot study to look into the connection between levels of toxicity in the gut and the probability of suffering side effects.

Dr. Ramesh Arasaradnam, from Warwick Medical School and gastroenterologist at University Hospitals Coventry & Warwickshire, summarized the outcome of the study findings. “In the simplest terms, we believe that patterns in toxicity levels arise from differences in a patient's gut microflora. By using this technology we can analyze stool samples and sniff out the chemicals that are produced by these microflora to better predict the risk of side effects.”

The pilot study’s success should lead to a wider study into the possible uses of these technologies and could be truly significant in helping clinicians inform patients receiving pelvic radiotherapy, before treatment is initiated. Dr. Arasaradnam clarified what this could suggest for radiotherapy patients, “In essence, we will be able to predict those who are likely to develop severe gut related side effects by the pattern of gut fermentation that are altered as a result of radiotherapy. This will enable future directed therapy in these high risk groups.”

Dr. James Covington, from the Warwick School of Engineering, added, “This technology offers considerable opportunities for the future. This shows just one application of being able to inform treatment by ‘sniffing’ patients. We foresee a time when such technology will become as routine a diagnostic test as checking blood pressure is today.”

In 2009, the same cutting edge gas sensor technology was taken from the automotive world and used to research into faster diagnosis for some gastrointestinal illnesses and metabolic disorders.

Related Links:
University of Warwick Medical School
Royal Marsden NHS Foundation Trust


Channels

MRI

view channel

Alzheimer’s Disease Linked to Specific Lifestyle Risk Factors

The results of a new study have found that cardiovascular risk factors such as smoking, alcohol consumption, diabetes, and obesity, can be linked directly to smaller brain volumes in specific areas of the brain, and to lower cognitive test scores. The study was published online in the Radiological Society of North America... Read more

Ultrasound

view channel

New Ultrasound System Enhances Patient Care and User Experience

A new ultrasound system with innovative specialized transducers and improved image quality, intended for general imaging, women’s health, and shared service applications, has been announced. The system features improved accuracy, performance, assessment tools, advanced automation, and an enhanced user experience.... Read more

Nuclear medicine

view channel

Clinical Study Shows Added Value of Amyloid PET Imaging in the Diagnosis and Treatment of Dementia

Early-onset dementia patients could benefit from a new PET imaging agent developed by a major medical imaging vendor. The results of a clinical study showing the effectiveness of the amyloid PET imaging agent were presented at the Alzheimer’s Association International Conference (AAIC 2015) in Washington DC (USA).... Read more

General/Advanced Imaging

view channel
Image: Illustration of a new technique using Optical Coherence Tomography that could help surgeons differentiate a human brain tumor, red, from surrounding noncancerous tissue, green (Photo courtesy of  Carmen Kut, Jordina Rincon-Torroella, Xingde Li and Alfredo Quinones-Hinojosa/Johns Hopkins Medicine).

Imaging Technique Helps Safer and More Effective Removal of Brain Tumors

Researchers at the Johns Hopkins University have demonstrated a new imaging technology that could enable neurosurgeons to better differentiate between healthy and cancerous brain tissue and perform safer... Read more

Imaging IT

view channel
Image: The Arbor Solution M2150 medical workstation with 21.5\

Multifunction Workstation Screen Meets Critical Certification Standards for Medical Environments

A medical imaging equipment vendor has unveiled a new workstation with a 54.61 cm true flat screen designed for operating rooms, clinical stations, and Picture Archiving and Communications Systems (PACS).... Read more

Industry News

view channel

Guerbet Aims for Global Medical Imaging Leadership by Acquisition of Mallinckrodt’s CMDS Business

Guerbet (Paris, France) has announced a definitive agreement for the acquisition of the Contrast Media and Delivery Systems (CMDS) business of pharmaceutical giant Mallinckrodt (Chesterfield, Derbyshire, UK). The acquisition gave Guerbet and the CMDS unit combined pro-forma sales of nearly EUR 800 million in 2014, a... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.